ZALEVSKY JONATHAN (Chief R&D Officer) sold 36.8% of their position (5.68K shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $397.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001193125-26-295112
Officer· Chief R&D Officer
Since Oct 2019
-5.68K
Net shares
Net seller
$397.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.68K
Price / share
$70.00
Trade value
$397.67K
% of position
36.8%
6/30/2026
15.44K→9.76K
Total
Net shares
−5.68K
Net value
-$397.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | S · Sale | −5.68K | $70.00 | $397.67K | 36.8% | 15.44K | 9.76K |
| Total | −5.68K | -$397.67K | ||||||
Derivative Transactions0
No derivative transactions reported